- X4 Pharmaceuticals (NASDAQ:XFOR) said it will conduct a one-for-thirty reverse stock split of the company’s common stock.
- The split will reduce the number of shares to ~5.8 million shares from 173.6 million shares.
- The company believes that the split will increase the market price for its common stock and help it meet the minimum bid price requirement.
X4 Pharmaceuticals to conduct reverse stock split (XFOR:NASDAQ)
